424 related articles for article (PubMed ID: 27868150)
1. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
3. Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
Keijsers RR; Joosten I; Hendriks AG; Koenen HJ; van Erp PE; van de Kerkhof PC
Exp Dermatol; 2015 Jan; 24(1):65-7. PubMed ID: 25355140
[TBL] [Abstract][Full Text] [Related]
4. Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model.
Satake K; Amano T; Okamoto T
Sci Rep; 2019 Nov; 9(1):16322. PubMed ID: 31705000
[TBL] [Abstract][Full Text] [Related]
5. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
[TBL] [Abstract][Full Text] [Related]
6. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions.
Dyring-Andersen B; Bonefeld CM; Bzorek M; Løvendorf MB; Lauritsen JP; Skov L; Geisler C
Scand J Immunol; 2015 Jul; 82(1):84-91. PubMed ID: 25904071
[TBL] [Abstract][Full Text] [Related]
7. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
[TBL] [Abstract][Full Text] [Related]
8. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Affleck AG; Bottomley JM; Auland M; Jackson P; Ryttov J
Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
[TBL] [Abstract][Full Text] [Related]
10. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
11. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
13. Circulating Th17 cell fluctuation in psoriatic patients treated with topical calcipotriol and betamethasone butyrate propionate.
Hino R; Kabashima R; Kawakami C; Sugita K; Nakamura M; Tokura Y
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):242-4. PubMed ID: 20477915
[No Abstract] [Full Text] [Related]
14. A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.
Duvetorp A; Levin LÅ; Engerstedt Mattsson E; Ryttig L
Acta Derm Venereol; 2019 Apr; 99(4):393-399. PubMed ID: 30628631
[TBL] [Abstract][Full Text] [Related]
15. Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
Røpke M; Bulai Livideanu C; Kaldate R; Snel A; Paul C
Br J Dermatol; 2018 Jan; 178(1):e33-e34. PubMed ID: 28722136
[No Abstract] [Full Text] [Related]
16. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Freeman K
Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
[TBL] [Abstract][Full Text] [Related]
17. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
Claréus BW; Houwing R; Sindrup JH; Wigchert S
Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
[TBL] [Abstract][Full Text] [Related]
18. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel.
Tan ES; Oon HH
Indian J Dermatol Venereol Leprol; 2016; 82(3):345-7. PubMed ID: 27088952
[No Abstract] [Full Text] [Related]
20. A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.
Lu L; Xuan M; Yan Y; Li G; Zhou L; Wen Z; Lu C
Trials; 2016 Oct; 17(1):482. PubMed ID: 27716422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]